Cardinal Health Inc. (NYSE:CAH) Chairman George S. Barrett sold 217,995 shares of the firm’s stock in a transaction dated Thursday, November 10th. The shares were sold at an average price of $71.29, for a total transaction of $15,540,863.55. Following the completion of the sale, the chairman now owns 682,226 shares of the company’s stock, valued at $48,635,891.54. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of Cardinal Health Inc. (NYSE:CAH) opened at 71.39 on Wednesday. The firm’s 50 day moving average is $73.51 and its 200-day moving average is $78.18. The company has a market cap of $22.85 billion, a PE ratio of 17.28 and a beta of 0.73. Cardinal Health Inc. has a 1-year low of $62.70 and a 1-year high of $91.23.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, October 31st. The company reported $1.24 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.03. The firm had revenue of $32 billion for the quarter, compared to analysts’ expectations of $31.12 billion. Cardinal Health had a net margin of 1.08% and a return on equity of 25.20%. The company’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.38 earnings per share. Equities analysts expect that Cardinal Health Inc. will post $5.47 earnings per share for the current year.

Insider Buying and Selling by Quarter for Cardinal Health (NYSE:CAH)

The business also recently announced a quarterly dividend, which will be paid on Sunday, January 15th. Shareholders of record on Tuesday, January 3rd will be paid a $0.4489 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Thursday, December 29th. Cardinal Health’s payout ratio is 43.58%.

CAH has been the subject of several research reports. Citigroup Inc. raised their price objective on shares of Cardinal Health from $87.00 to $93.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 3rd. Leerink Swann restated a “buy” rating on shares of Cardinal Health in a research report on Wednesday, August 3rd. Deutsche Bank AG raised their price objective on shares of Cardinal Health from $83.00 to $89.00 and gave the stock a “hold” rating in a research report on Thursday, August 4th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Credit Suisse Group AG restated a “buy” rating and set a $97.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 30th. Ten investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $91.62.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charlemagne Capital Ltd. boosted its position in Cardinal Health by 0.4% in the second quarter. Charlemagne Capital Ltd. now owns 2,527 shares of the company’s stock worth $196,000 after buying an additional 10 shares during the last quarter. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 0.8% in the third quarter. Alpha Windward LLC now owns 2,133 shares of the company’s stock worth $166,000 after buying an additional 16 shares during the last quarter. KCM Investment Advisors LLC boosted its stake in shares of Cardinal Health by 0.3% in the third quarter. KCM Investment Advisors LLC now owns 5,778 shares of the company’s stock worth $449,000 after buying an additional 17 shares during the last quarter. Bridgewater Wealth & Financial Management LLC boosted its stake in shares of Cardinal Health by 0.3% in the second quarter. Bridgewater Wealth & Financial Management LLC now owns 6,561 shares of the company’s stock worth $512,000 after buying an additional 19 shares during the last quarter. Finally, Conning Inc. boosted its stake in shares of Cardinal Health by 0.3% in the second quarter. Conning Inc. now owns 7,980 shares of the company’s stock worth $623,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 88.19% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

5 Day Chart for NYSE:CAH

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.